Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Current Deferred Tax Assets (2013 - 2015)

Incyte's (INCY) quarterly Current Deferred Tax Assets came in at $9.7 million in Q3 2015, up 1153.16% YoY from $775000.0 in Q3 2014, and up 25.72% on a QoQ basis from $7.7 million in Q2 2015.

Analysis

Incyte (INCY) Current Deferred Tax Assets (2013 - 2015) Analysis & Trends

Incyte (INCY) has 3 years of Current Deferred Tax Assets data on file, last reported at $9.7 million in Q3 2015.

  • Quarterly Current Deferred Tax Assets rose 1153.16% year-over-year to $9.7 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $9.7 million (up 1153.16% YoY) and the FY2014 annual result came in at $19.6 million, up 2094.53% from the prior year.
  • Current Deferred Tax Assets climbed to $9.7 million in Q3 2015, from $7.7 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $19.6 million in Q4 2014 to a low of $775000.0 in Q3 2014.
  • A 3-year average of $5.8 million and a median of $3.5 million in 2014 frame the typical range for Current Deferred Tax Assets.
  • Annual changes were most pronounced in 2014 — Current Deferred Tax Assets surged 2094.53% — and 2015, when it jumped 575.45%.
  • Tracing INCY's Current Deferred Tax Assets over 3 years: stood at $895000.0 in 2013, then surged by 2094.53% to $19.6 million in 2014, then sank by 50.55% to $9.7 million in 2015.
  • The last three Current Deferred Tax Assets figures came in at $9.7 million (Q3 2015), $7.7 million (Q2 2015), and $6.0 million (Q1 2015), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 9.71 Mn
Jun 30, 2015 7.73 Mn
Mar 31, 2015 6.03 Mn
Dec 31, 2014 19.64 Mn
Sep 30, 2014 775,000.00
Jun 30, 2014 900,000.00
Mar 31, 2014 892,000.00
Dec 31, 2013 895,000.00